Nicholas Fitz, PhD Linkedin Utilizing a multi-targeted approach my main research goal is to increase the understanding of how changes in gene function and apolipoprotein expression alters Alzheimer’s disease progression. During my graduate and post-doctoral training I received a broad training in utilizing animal models of neurodegenerative disease to test changes in cognition and biological […]
John Fryer, PhD Linkedin Twitter Google Dr. Fryer received his BS in microbiology at the University of Arizona before joining the lab of Dr. David Hotlzman, MD, at Washington University in St. Louis. There he studied mechanisms of amyloid formation in parenchyma and cerebral vessels in mouse models. After completing his Ph.D. in 2005, he
Thomas Kukar, PhD Linkedin Twitter Google Our lab studies the pathogenesis of neurodegenerative diseases to guide development of novel therapeutics. We focus on Frontotemporal dementia (FTD), Amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease (AD). The goal of my laboratory is to develop new strategies to treat neurodegenerative diseases. We aim to understand the pathogenesis of these diseases by
Hu Li, PhD Linkedin Dr. Li’s team are focused on systems biology, systems pharmacology and individualized systems medicine. Li’s team is active in developing novel network tools and harnessing machine learning methods to study context-dependent activities of regulatory networks at genome-wide scale. The major theme in the research team is to develop novel computational methods
